Literature DB >> 17035499

Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.

Ruiru Shi1, Jianyuan Zhang, Chuanyou Li, Yuko Kazumi, Isamu Sugawara.   

Abstract

A high rate of double point mutations in gyrA (56% of 87 ofloxacin-resistant Mycobacterium tuberculosis clinical isolates) indicates the emergence of fluoroquinolone resistance. This is the first report to describe denaturing high-pressure liquid chromatography analysis of mutations in gyrA of M. tuberculosis in a large number of clinical isolates.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17035499      PMCID： PMC1698392          DOI： 10.1128/JCM.01916-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms.

Authors:  Robert C Cooksey; Glenn P Morlock; Brian P Holloway; Josef Limor; Michael Hepburn
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Development of fluoroquinolones as first-line drugs for tuberculosis--at long last!

Authors:  Richard J O'Brien
Journal:  Am J Respir Crit Care Med       Date:  2003-12-01       Impact factor: 21.405

3.  Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease.

Authors:  Ruiru Shi; Koji Otomo; Hiroyuki Yamada; Taiga Tatsumi; Isamu Sugawara
Journal:  Microbes Infect       Date:  2005-08-10       Impact factor: 2.700

4.  Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis.

Authors:  C Xu; B N Kreiswirth; S Sreevatsan; J M Musser; K Drlica
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.

Authors:  Amy Sarah Ginsburg; Ronggai Sun; Heather Calamita; Cherise P Scott; William R Bishai; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 6.  Fluoroquinolones, tuberculosis, and resistance.

Authors:  Amy Sarah Ginsburg; Jacques H Grosset; William R Bishai
Journal:  Lancet Infect Dis       Date:  2003-07       Impact factor: 25.071

7.  Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography.

Authors:  Amr M Mohamed; Dhundy R Bastola; Glenn P Morlock; Robert C Cooksey; Steven H Hinrichs
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.

Authors:  T Kocagöz; C J Hackbarth; I Unsal; E Y Rosenberg; H Nikaido; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.

Authors:  Augustine F B Cheng; Wing W Yew; Edward W C Chan; Miu L Chin; Mamie M M Hui; Raphael C Y Chan
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

10.  Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.

Authors:  G J Alangaden; E K Manavathu; S B Vakulenko; N M Zvonok; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
View more
  24 in total

Review 1.  A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.

Authors:  Fernanda Maruri; Timothy R Sterling; Anne W Kaiga; Amondrea Blackman; Yuri F van der Heijden; Claudine Mayer; Emmanuelle Cambau; Alexandra Aubry
Journal:  J Antimicrob Chemother       Date:  2012-01-25       Impact factor: 5.790

2.  Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.

Authors:  Kanchan Ajbani; Camilla Rodrigues; Shubhada Shenai; Ajita Mehta
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

3.  Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.

Authors:  Ruiru Shi; Jianyuan Zhang; Koji Otomo; Guolong Zhang; Isamu Sugawara
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

Review 4.  Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.

Authors:  Hanna Nebenzahl-Guimaraes; Karen R Jacobson; Maha R Farhat; Megan B Murray
Journal:  J Antimicrob Chemother       Date:  2013-09-20       Impact factor: 5.790

5.  High-resolution melting curve analysis for rapid detection of rifampin resistance in Mycobacterium tuberculosis: a meta-analysis.

Authors:  Xiaomao Yin; Lei Zheng; Qinlan Liu; Li Lin; Xiumei Hu; Yanwei Hu; Qian Wang
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

6.  Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing.

Authors:  E M Streicher; I Bergval; K Dheda; E C Böttger; N C Gey van Pittius; M Bosman; G Coetzee; R M Anthony; P D van Helden; T C Victor; R M Warren
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

7.  Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.

Authors:  Yingda L Xie; Soumitesh Chakravorty; Derek T Armstrong; Sandra L Hall; Laura E Via; Taeksun Song; Xing Yuan; Xiaoying Mo; Hong Zhu; Peng Xu; Qian Gao; Myungsun Lee; Jongseok Lee; Laura E Smith; Ray Y Chen; Joon Sung Joh; YoungSoo Cho; Xin Liu; Xianglin Ruan; Lili Liang; Nila Dharan; Sang-Nae Cho; Clifton E Barry; Jerrold J Ellner; Susan E Dorman; David Alland
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

8.  Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.

Authors:  Lulette Tricia C Bravo; Marion J Tuohy; Concepcion Ang; Raul V Destura; Myrna Mendoza; Gary W Procop; Steven M Gordon; Geraldine S Hall; Nabin K Shrestha
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

9.  Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.

Authors:  Ritu Singhal; Paul R Reynolds; Jamie L Marola; L Elaine Epperson; Jyoti Arora; Rohit Sarin; Vithal Prasad Myneedu; Michael Strong; Max Salfinger
Journal:  J Clin Microbiol       Date:  2016-06-22       Impact factor: 5.948

10.  Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China.

Authors:  Peng Xu; Xia Li; Ming Zhao; Xiaohong Gui; Kathryn DeRiemer; Sebastien Gagneux; Jian Mei; Qian Gao
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.